Literature DB >> 10942167

Estrogen increases eNOS and NOx release in human coronary artery endothelium.

S Yang1, L Bae, L Zhang.   

Abstract

Estrogen protects against the development of coronary heart disease in women. This study was designed to examine the direct effects of estrogen on nitric oxide release and endothelial nitric oxide synthase (eNOS) expression in cultured human coronary artery endothelial cells (HCAECs). NOx (nitrate, nitrite, and nitric oxide) was measured by the chemiluminescence method. Prolonged treatment (48 h) of the cells with 17beta-estradiol (E2beta), but not 17alpha-estradiol (E2alpha), resulted in a 2.3-fold increase in basal NOx release in HCAECs and an enhanced adenosine triphosphate (ATP)- and calcium ionophore A23187-induced NOx release. The effects of E2beta on endothelial NOx release were blocked by estrogen-receptor antagonist ICI 182,780. E2beta had no effect on basal and ATP-stimulated intracellular Ca2+ concentrations in HCAECs. However, E2beta significantly increased eNOS protein levels, as determined by Western analysis. We conclude that estrogen increases NOx release in HCAECs, which is independent of cytosolic Ca2+ mobilization and is mediated by the upregulation of eNOS.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10942167     DOI: 10.1097/00005344-200008000-00015

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  27 in total

Review 1.  Hormone replacement therapy for prevention of coronary heart disease: current evidence.

Authors:  P S Khurana; C Khurana; J Hsia
Journal:  Curr Atheroscler Rep       Date:  2001-09       Impact factor: 5.113

2.  Estrogen dependence of the renal vasodilatory effect of nicotine in rats: role of α7 nicotinic cholinergic receptor/eNOS signaling.

Authors:  Mahmoud M el-Mas; Sahar M el-Gowilly; Eman Y Gohar; Abdel-Rheem M Ghazal; Abdel A Abdel-Rahman
Journal:  Life Sci       Date:  2010-11-16       Impact factor: 5.037

Review 3.  Age-related endothelial dysfunction : potential implications for pharmacotherapy.

Authors:  Rachel L Matz; Ramaroson Andriantsitohaina
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

Review 4.  Adventures in vascular biology: a tale of two mediators.

Authors:  S Moncada
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2006-05-29       Impact factor: 6.237

Review 5.  Regulation of cellular communication by signaling microdomains in the blood vessel wall.

Authors:  Marie Billaud; Alexander W Lohman; Scott R Johnstone; Lauren A Biwer; Stephanie Mutchler; Brant E Isakson
Journal:  Pharmacol Rev       Date:  2014-03-26       Impact factor: 25.468

6.  Sex and nitric oxide bioavailability interact to modulate interstitial Po2 in healthy rat skeletal muscle.

Authors:  Jesse C Craig; Trenton D Colburn; Daniel M Hirai; Michael J Schettler; Timothy I Musch; David C Poole
Journal:  J Appl Physiol (1985)       Date:  2018-01-25

Review 7.  Somewhere over the sex differences rainbow of myocardial infarction remodeling: hormones, chromosomes, inflammasome, oh my.

Authors:  Kristine Y DeLeon-Pennell; Merry L Lindsey
Journal:  Expert Rev Proteomics       Date:  2019-09-11       Impact factor: 3.940

8.  Protective role of normothermic, hyperthermic and estrogen preconditioning and pretreatment on tumour necrosis factor-alpha-induced damage.

Authors:  Jasbir S Juggi; Lamia J Hoteit; Fawzi A Babiker; Shaji Joseph; Abu Salim Mustafa
Journal:  Exp Clin Cardiol       Date:  2011

9.  Endothelial nitric oxide synthase gene variants and primary open-angle glaucoma: interactions with sex and postmenopausal hormone use.

Authors:  Jae Hee Kang; Janey L Wiggs; Bernard A Rosner; Susan E Hankinson; Wael Abdrabou; Bao Jian Fan; Jonathan Haines; Louis R Pasquale
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-10-08       Impact factor: 4.799

Review 10.  Nitric oxide and coronary vascular endothelium adaptations in hypertension.

Authors:  Andrew S Levy; Justin C S Chung; Jeffrey T Kroetsch; James W E Rush
Journal:  Vasc Health Risk Manag       Date:  2009-12-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.